Romidepsin (Istodax)
Showing 1 - 25 of 66
Recurrent Anaplastic Large Cell Lymphoma, Recurrent Angioimmunoblastic T-Cell Lymphoma, Recurrent Mature T- and NK-Cell
Active, not recruiting
- Recurrent Anaplastic Large Cell Lymphoma
- +10 more
- Pembrolizumab
- Romidepsin
-
Houston, TexasM D Anderson Cancer Center
Jan 30, 2023
Cutaneous T-cell Lymphoma, T-Prolymphocytic Leukemia, T-Large Granulocytic Leukemia Trial in Columbus (Romidepsin, Busulfan,
Recruiting
- Cutaneous T-cell Lymphoma
- +4 more
- Romidepsin
- +4 more
-
Columbus, OhioThe Ohio State University Cancer Center
Apr 18, 2022
Anaplastic Large Cell Lymphoma, Recurrent Mature T-Cell and NK-Cell Non-Hodgkin Lymphoma, Refractory Mature T-Cell and NK-Cell
Active, not recruiting
- Anaplastic Large Cell Lymphoma
- +2 more
- Laboratory Biomarker Analysis
- +2 more
-
Duarte, California
- +1 more
Jul 26, 2022
Colorectal Cancer Trial in Baltimore (Oral CC-486, Romidepsin, MK-3475)
Completed
- Colorectal Cancer
- Oral CC-486
- +2 more
-
Baltimore, MarylandJohns Hopkins Sidney Kimmel Comprehensive Cancer Center
Mar 21, 2022
Recurrent Anaplastic Large Cell Lymphoma, Recurrent Mature T-Cell and NK-Cell Non-Hodgkin Lymphoma, Recurrent Primary Cutaneous
Recruiting
- Recurrent Anaplastic Large Cell Lymphoma
- +8 more
-
Columbus, OhioOhio State University Comprehensive Cancer Center
Apr 6, 2022
Lymphoma, T-Cell, Cutaneous, Lymphoma, T-Cell, Peripheral, Hodgkin Disease Trial in Chicago, Saint Louis (Romidepsin,
Completed
- Lymphoma, T-Cell, Cutaneous
- +3 more
- Romidepsin
- +4 more
-
Chicago, Illinois
- +1 more
Nov 16, 2020
HIV Trial in United States (Romidepsin, Placebo for Romidepsin)
Lung Cancer, Metastatic Cancer Trial in Dallas (Erlotinib plus Romidepsin (8 mg/m^2), Erlotinib plus Romidepsin (10 mg/m^2),
Completed
- Lung Cancer
- Metastatic Cancer
- Erlotinib plus Romidepsin (8 mg/m^2)
- +3 more
-
Dallas, TexasSimmons Comprehensive Cancer Center at University of Texas South
Jan 18, 2021
Hodgkin's Lymphoma, Mature T-cell Lymphoma, Multiple Myeloma Trial in New Haven (lenalidomide (Revlimid) and romidepsin
Terminated
- Hodgkin's Lymphoma
- +2 more
- lenalidomide (Revlimid) and romidepsin (Istodax)
-
New Haven, ConnecticutYale Cancer Center
Mar 2, 2020
Lymphoid Malignancies, Lymphoma, Hodgkin Lymphoma Trial in New York (Romidepsin, Oral 5-Azacitidine)
Terminated
- Lymphoid Malignancies
- +3 more
- Romidepsin
- Oral 5-Azacitidine
-
New York, New YorkColumbia University Medical Center
Jan 5, 2021
Lymphoma, T-Cell, Peripheral Trial in United States (Romidepsin, Ixazomib)
Active, not recruiting
- Lymphoma, T-Cell, Peripheral
-
Chicago, Illinois
- +6 more
Jan 15, 2021
Relapsed Angioimmunoblastic T-Cell Lymphoma, Refractory Angioimmunoblastic T-cell Lymphoma Trial in Worldwide (Oral azacitidine,
Active, not recruiting
- Relapsed Angioimmunoblastic T-Cell Lymphoma
- Refractory Angioimmunoblastic T-cell Lymphoma
- Oral azacitidine
- +3 more
-
Graz, Austria
- +33 more
Aug 24, 2022
Multiple Myeloma, Non-Hodgkin's Lymphoma Trial in United States (Romidepsin, Lenalidomide)
Active, not recruiting
- Multiple Myeloma
- Non-Hodgkin's Lymphoma
-
Hartford, Connecticut
- +6 more
Jan 3, 2023
Stage IV Squamous Cell Carcinoma of the Hypopharynx, Stage IV Squamous Cell Carcinoma of the Larynx, Stage IV Squamous Cell
Completed
- Stage IV Squamous Cell Carcinoma of the Hypopharynx
- +3 more
-
Boston, Massachusetts
- +1 more
Feb 11, 2021
Lymphoid Malignancies, Multiple Myeloma, Lymphoma Trial in Boston, New York (Pralatrexate, Romidepsin)
Unknown status
- Lymphoid Malignancies
- +4 more
-
Boston, Massachusetts
- +1 more
Feb 6, 2020
Pancreatic Cancer Trial in Nashville (Romidepsin, Gemcitabine)
Completed
- Pancreatic Cancer
-
Nashville, TennesseeSarah Cannon Research Institute
Oct 16, 2019
Hematologic Malignancy, Malignant Lymphoma Trial in Sarasota, Nashville, London (Romidepsin, Rifampin)
Completed
- Hematologic Malignancy
- Malignant Lymphoma
-
Sarasota, Florida
- +2 more
Nov 14, 2019
Hematologic Malignancy, Malignant Lymphoma Trial in Sarasota, Nashville, London (Romidepsin, Ketoconazole)
Completed
- Hematologic Malignancy
- Malignant Lymphoma
-
Sarasota, Florida
- +2 more
Nov 14, 2019